Literature DB >> 16803678

Molecular interactions of leptin and prostate cancer.

Radhika Gade-Andavolu1, Lawrence A Cone, Shinger Shu, Ariela Morrow, Beena Kowshik, Murthy V S Andavolu.   

Abstract

BACKGROUND: Epidemiological studies have found obesity to be a risk factor for prostate cancer. Our prior independent studies in women have reported a strong relationship between variants of OB (leptin) gene, body mass index, and age at menarche and sporadic breast cancer. The current study investigates an association between genetic variants of the human obesity gene, serum leptin levels, and body mass index in subjects with prostate carcinoma and in age- and gender-matched normal subjects.
METHODS: Blood samples from 69 patients with prostate cancer and 137 age-matched control subjects were collected. Serum leptin level was investigated by radioimmunoassay, and body mass index was calculated. Allele sizes were determined via standard polymerase chain reaction. Statistical analysis was performed using SPSS10.0 computer software.
RESULTS: There was a strong association with significantly elevated serum leptin levels, high body mass index, and higher frequency of LEPR longer alleles in patients with prostate cancer than in control subjects. By contrast, a modest but not significant increase in the frequency of LEP short alleles was found in patients with prostate cancer as compared with control subjects. Analysis within groups 1 (low leptin level and low body mass index) and 2 (other) showed a significant association only in group 2, with high frequency of OB gene variants (LEPR long alleles and LEP short alleles) in patients with prostate cancer but not in control subjects.
CONCLUSIONS: These results represent the first report of a significant association between specific leptin gene alleles, serum leptin levels, and body mass index in subjects with prostate cancer. Consistent with prior reports, we also report a significantly elevated serum leptin level in patients with prostate cancer, suggesting a strong link with obesity as an increased risk factor.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16803678     DOI: 10.1097/00130404-200605000-00008

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  8 in total

1.  Adipokine genes and prostate cancer risk.

Authors:  Steven C Moore; Michael F Leitzmann; Demetrius Albanes; Stephanie J Weinstein; Kirk Snyder; Jarmo Virtamo; Jiyoung Ahn; Susan T Mayne; Herbert Yu; Ulrike Peters; Marc J Gunter
Journal:  Int J Cancer       Date:  2009-02-15       Impact factor: 7.396

Review 2.  Dietary intervention in the management of prostate cancer.

Authors:  Wendy Demark-Wahnefried; Mark A Moyad; Mark M Moyad
Journal:  Curr Opin Urol       Date:  2007-05       Impact factor: 2.309

3.  Dietary soy and tea combinations for prevention of breast and prostate cancers by targeting metabolic syndrome elements in mice.

Authors:  Jin-Rong Zhou; Linglin Li; Weijun Pan
Journal:  Am J Clin Nutr       Date:  2007-09       Impact factor: 7.045

4.  The adipocyte-derived hormone leptin has proliferative actions on androgen-resistant prostate cancer cells linking obesity to advanced stages of prostate cancer.

Authors:  M Raschid Hoda; Gerit Theil; Nasreldin Mohammed; Kersten Fischer; Paolo Fornara
Journal:  J Oncol       Date:  2012-05-28       Impact factor: 4.375

Review 5.  Genetic polymorphisms in leptin, adiponectin and their receptors affect risk and aggressiveness of prostate cancer: evidence from a meta-analysis and pooled-review.

Authors:  Meng-Bo Hu; Hua Xu; Ji-Meng Hu; Wen-Hui Zhu; Tian Yang; Hao-Wen Jiang; Qiang Ding
Journal:  Oncotarget       Date:  2016-12-06

6.  Relationship of self-reported body size and shape with risk for prostate cancer: A UK case-control study.

Authors:  Mohammad Aladwani; Artitaya Lophatananon; Fredie Robinson; Aneela Rahman; William Ollier; Zsofia Kote-Jarai; David Dearnaley; Govindasami Koveela; Nafisa Hussain; Reshma Rageevakumar; Diana Keating; Andrea Osborne; Tokhir Dadaev; Mark Brook; Rosalind Eeles; Kenneth R Muir
Journal:  PLoS One       Date:  2020-09-17       Impact factor: 3.240

7.  Association of serum leptin with breast cancer: A meta-analysis.

Authors:  Li Gu; Cheng-Di Wang; Chang Cao; Lin-Rui Cai; De-Hua Li; Yu-Zhen Zheng
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

8.  Circulating adiponectin and leptin and risk of overall and aggressive prostate cancer: a systematic review and meta-analysis.

Authors:  Anya J Burton; Rebecca Gilbert; Kate Tilling; Ryan Langdon; Jenny L Donovan; Jeff M P Holly; Richard M Martin
Journal:  Sci Rep       Date:  2021-01-11       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.